Vasista, A., Martin, A., Pavlakis, N., Sjoquist, K., Snow, S., Jonker, D., … Kiely, B. (2017). Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in a Randomized Phase 2 Trial of Regorafenib in Advanced Gastric Cancer. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 13, pp. 47–48). WILEY.

Vasista, A., A. Martin, N. Pavlakis, K. Sjoquist, S. Snow, D. Jonker, Y. J. Chua, et al. “Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in a Randomized Phase 2 Trial of Regorafenib in Advanced Gastric Cancer.” In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 13:47–48. WILEY, 2017.

Vasista A, Martin A, Pavlakis N, Sjoquist K, Snow S, Jonker D, et al. Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in a Randomized Phase 2 Trial of Regorafenib in Advanced Gastric Cancer. In: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2017. p. 47–8.

Vasista, A., et al. “Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in a Randomized Phase 2 Trial of Regorafenib in Advanced Gastric Cancer.” ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 13, WILEY, 2017, pp. 47–48.

Vasista A, Martin A, Pavlakis N, Sjoquist K, Snow S, Jonker D, Chua YJ, Epstein R, Bonaventura A, Khasraw M, Varma S, Singhal N, Ransom D, Aubin F, Burkes R, Lim H, Lemay F, Begbie S, Stockler M, Kiely B. Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in a Randomized Phase 2 Trial of Regorafenib in Advanced Gastric Cancer. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2017. p. 47–48.